alpha(1)-adrenoceptor-induced contractility in rat aorta is mediated by the alpha(1D) subtype

被引:107
作者
Buckner, SA
Oheim, KW
Morse, PA
Knepper, SM
Hancock, AA
机构
[1] Abbott Laboratories, D47C AP9, Abbott Park, IL 60064-3500
关键词
alpha(1D)-adrenoceptor; radioligand binding; contractility; aorta; rat;
D O I
10.1016/0014-2999(95)00755-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adrenoceptor agonists were used to characterize the alpha(1)-adrenoceptor subtype responsible for mediating tension (phasic and tonic combined) in the denuded rat aorta and compared with radioligand binding at alpha(1)-adrenoceptor subtypes. The rank order of potency at the rat aorta was the same as that obtained for binding affinity at the rat clonal alpha(1d)-adrenoceptor: norepinephrine > epinephrine > cirazoline > phenylephrine > oxymetazoline > A-61603 > methoxamine. Correlation coefficients comparing rat aortic contraction (pD(2)) to binding (pK(i)) were 0.09-0.21 for alpha(1A/a) receptors, 0.66 for clonal alpha(1b) and 0.94 for clonal alpha(1d)-adrenoceptors. Correlation coefficients comparing the clonal alpha(1d)-adrenoceptor binding affinity to in vitro contractile responses were 0.03 and 0.10 for the rat vas deferens and canine prostate alpha(1A)-adrenoceptor responses, respectively, 0.09 for the rat spleen alpha(1B) and as noted, 0.94 for the rat aorta. The agreement observed between agonist potency at the rat aorta and affinity for the alpha(1d) binding sire provide new evidence that the alpha(1D)-adrenoceptor subtype is responsible for mediating contractions in the rat aorta.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 26 条
[1]   INVESTIGATION OF THE SUBTYPES OF ALPHA-1-ADRENOCEPTOR MEDIATING CONTRACTIONS OF RAT AORTA, VAS-DEFERENS AND SPLEEN [J].
ABOUD, R ;
SHAFII, M ;
DOCHERTY, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (01) :80-87
[2]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[3]   CALCIUM-ANTAGONISTS INHIBIT CONTRACTIONS TO NOREPINEPHRINE IN THE RAT AORTA, IN THE ABSENCE, BUT NOT IN THE PRESENCE OF THE ENDOTHELIUM [J].
AUCHSCHWELK, W ;
VANHOUTTE, PM .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1991, 22 (04) :595-602
[4]  
BYLUND DB, 1994, PHARMACOL REV, V46, P121
[5]   SIMULTANEOUS ANALYSIS OF FAMILIES OF SIGMOIDAL CURVES - APPLICATION TO BIOASSAY, RADIOLIGAND ASSAY, AND PHYSIOLOGICAL DOSE-RESPONSE CURVES [J].
DELEAN, A ;
MUNSON, PJ ;
RODBARD, D .
AMERICAN JOURNAL OF PHYSIOLOGY, 1978, 235 (02) :E97-E102
[6]   ALPHA-1-ADRENOCEPTOR CLASSIFICATION - SHARPENING OCCAM RAZOR [J].
FORD, APDW ;
WILLIAMS, TJ ;
BLUE, DR ;
CLARKE, DE .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (06) :167-170
[7]   A-75169 HCL - PHARMACOLOGICAL PROFILE AND OCULAR PHARMACOLOGY STUDIES OF A NEW ALPHA-2 ANTAGONIST [J].
GIARDINA, WJ ;
BUCKNER, SA ;
HANCOCK, AA ;
LEE, JY ;
WISMER, CT ;
DEBERNARDIS, JF .
DRUG DEVELOPMENT RESEARCH, 1993, 28 (01) :56-64
[8]  
GOETZ A, 1994, EUR J PHARMACOL, V272, pR5
[9]   BINDING CHARACTERISTICS OF PRAZOSIN-H-3 TO RAT-BRAIN ALPHA-ADRENERGIC RECEPTORS [J].
GREENGRASS, P ;
BREMNER, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 55 (03) :323-326
[10]   5-METHYL-URAPIDIL DISCRIMINATES BETWEEN SUBTYPES OF THE ALPHA-1-ADRENOCEPTOR [J].
GROSS, G ;
HANFT, G ;
RUGEVICS, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (02) :333-335